Announcements, events, funding opportunities and more news for the Mass General Research Institute community. | |
In this edition:
Funding Opportunities
- Damon Runyon Clinical Investigator Award
- Interim Support Funding 25-1
- Smith Family Foundation Odyssey Award
- Increasing the Impact of Clinical Research on Human Health
-
NEW! The Center for Suicide Research and Prevention (CSRP) Scholars Program
-
NEW! The Center for Suicide Research and Prevention (CSRP) Pilot Grant Program
- The MGH Claflin Distinguished Scholar Awards for Junior Faculty Women Investigators
- Limited Submission Funding
- Foundation Funding Opportunities
Announcements:
- Apply for the 2025 Claflin Consultation Initiative
Events:
-
TODAY! Speed Mentoring Hour
-
MONDAY AT 4! Faculty Transition Webinar Series S1 - "Successful Transition to Retirement While Balancing Continued Engagement at MGH"
- A Practical Guide to Leveraging the Mass General Brigham Biobank and All of Us Research Program for Genetic and Biomarker Research
- Course: Qualitative and Mixed Methods: Mixed Methods Research
-
Gene and Cell Therapy Research Symposium
- Drop-In Sessions for CRC's
-
Imaging Data Commons: Data + Tools + Compute to Power Your AI Explorations
- Boston Angiogenesis Meeting 2024
-
NEW! Fun Fridays- Eight Active Ingredients of Tai Chi©
- REDCap MyCap
- Research Recharge
- Parenting Series 2024-2025: “The Ins and Outs of Paternity Leave”
- Clinical Trial Opportunities for Young Investigators: Partnering with the TCRC
- Claflin Distinguished Scholar Awards Panel Discussion
-
NEW! Biobank Portal
- “How Do You Feel?”, a moderated discussion with Dr. Jessi Gold
-
Maurizio Fava Lecture Series on Well-Being: “Reading Kafka in the Hospital Cafeteria - Reflections on 17 years of Literature and Medicine at MGH”
-
NEW! Course: Introduction to RPDR
-
NEW! Course: Conquering the K Workshop
-
NEW! Course: REDCap eConsent Functionality
-
NEW! Summit: Transforming Post-Acute Care Access for Severe Traumatic Brain Injury
- Endocrine Grand Rounds: 36th Annual Farahe Maloof Lectureship: “Strategic Treatment of Anaplastic Thyroid Cancer: The Reach for a Cure”
-
NEW! Course: Introduction to 10x Single-Cell Platforms and Workflows
-
NEW! Parenting Series 2024-2025: “What Parents Should Know about Gender Diversity in Kids and Teens”
-
Two Meditation Sessions available every week
| |
Damon Runyon Clinical Investigator Award
The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments.
MGH is eligible to nominate a maximum of five (5) candidates.
$600,000 for a period of three years. Funding in the amount of $200,000 will be allocated to the awardee’s institution each year for the support of the Clinical Investigator. No part of this grant can be used for indirect costs or institutional overhead.
MGH letter of intent deadline: Wednesday, November 13, 2024 at 5:00pm
Sponsor deadline: Monday, February 3, 2025 at 4:00pm
| |
INTERIM SUPPORT FUNDING 25-1
The Executive Committee on Research (ECOR) is now accepting applications for Interim Support Funding.
What are they?
Interim Support Funding
The Interim Support Funding (ISF) Program is open to Principal Investigators during a lapse or delay in their research funding from the NIH or another Federal agency (e.g., the National Science Foundation, the Department of Defense). Investigators must have applied for independent, long-term support (R01, R21, U01, P01, equivalent federal research grant). The intent of the program is to rescue strong scientific programs that are in need of bridge funding in order to sustain their research. Applications will be accepted regardless of percentile or score, including applications that were not discussed.
When is the deadline?
Monday, December 2, 2024 - 5:00 PM
How do I learn more and apply?
Interim Support Funding - Click here
| |
Smith Family Foundation Odyssey Award
A program of the Richard and Susan Smith Family Foundation
What are they?
The Smith Family Foundation Odyssey Award was created in 2017 to fuel creativity and innovation in junior investigators in the basic sciences. The Award supports the pursuit of high impact ideas to generate breakthroughs and drive new directions in biomedical research. The awards will fund high-risk, high-reward pilot projects. Projects should be conceptualized as a novel research line and a distinct and novel off-shoot from the applicant’s current research.
Eligible applicants must be junior investigators who received their first independent faculty appointment on or between November 1, 2016 and November 1, 2021.
There is no longer a limit on the number of applications from a given institution. Applicants no longer need to be internally selected and nominated by their institutions. Please apply directly to the sponsor.
How much is the award?
The award is $400,000 over two years ($200,000 per year) inclusive of 5% IDC
When is the deadline?
Tuesday, December 17, 2024 at 12:00 Noon
How do I learn more about the opportunity?
Smith Family Foundation: Odyssey Award – Click here
| |
Increasing the Impact of Clinical Research on Human Health
Request for Applications (RFA)
Applications due: January 15, 2025
Highlights:
- Funding: $25,000 - $50,000 per award, up to eight awards available
- Applications due: January 15, 2025
This pilot funding opportunity focuses on potential solutions to common roadblocks that impact faculty, research staff, and other communities in the conduct of research on human health.
Background: The National Center for Advancing Translational Sciences (NCATS) requires all clinical and translational science centers, including Harvard Catalyst, to use translational science methodologies to identify and mitigate roadblocks impeding health-related research at their local institutions. Through multiple outreach formats across Harvard University schools and affiliated hospitals, Harvard Catalyst identified translational roadblocks that faculty and other employees felt limited the breadth and impact of research on human health. These formed the basis for initiatives proposed in Harvard Catalyst’s current NCATS award and several are addressed by this pilot opportunity.
This request for applications (RFA) invites proposals for innovative pilot projects that address some aspect of any one of the following three translational roadblocks:
- Research and clinical data need to be connected and their access democratized.
- The clinical translational research (CTR) workforce is not sufficiently diverse and must be grown in all domains.
- Insufficient mechanisms exist to support implementation of CTR evidence into practice.
Examples illustrating the broad range of responsive proposals can be found in the full program announcement posted on the website.
It is important that clinical research moves toward a greater emphasis on translational science research, the outcomes of which will increase the impact of clinical research on human health. Your participation can drive meaningful change.
In accord with the above mandate, this RFA seeks studies that explore or demonstrate how a range of processes, assessments, models, or modifications can inform clinical translational research more generally, rather than asking for proposals focused on a specific aspect of a highly-defined clinical question or setting.
Applications are due January 15, 2025.
Visit our website for more information, including application details, examples of projects that might be proposed, the NCATS definition of translational science, and key dates. Please do not hesitate to email us at grants@catalyst.harvard.edu if you have any questions or require further information.
| |
The Center for Suicide Research and Prevention
(CSRP) Scholars Program
Applications due January 24, 2025 @5:00 PM ET
The Center for Suicide Research and Prevention (CSRP) is a multidisciplinary, practice-based center aimed at advancing and implementing innovative new suicide prevention research. It will support the development, deployment, and evaluation of practice-ready and clinically focused interventions aimed at improving the identification and effective treatment of patients at risk of suicide. The CSRP is now accepting applications for the Collaborating Scholars Program in order to support innovative early career and advanced investigators with an interest in suicide research.
Award Amount:
The Scholars Program provides up to $50,000 in salary support for one (1) year.
Funding Period:
June 1st, 2025 – May 31st, 2026.
Have other questions? Contact MGHCSRP@MGB.ORG
| |
The Center for Suicide Research and Prevention
(CSRP) Pilot Grant Program
Applications due January 24, 2025 @5:00 PM ET
The NIMH-funded practice-based Center for Suicide Research and Prevention (CSRP) at Mass General Brigham and Harvard University Faculty of Arts and Sciences, is a multidisciplinary center aimed at advancing and implementing innovative research. In alignment with the NIMH and CSRP’s mission to support burgeoning research in suicide prediction and prevention, the CSRP is now accepting applications for pilot grant funding.
Award Amount:
Selected projects will receive up to $50,000 in direct costs to advance their research for one (1) year. Funds can be used flexibly to support salary or research costs.
Funding Period:
June 1st, 2025 – May 31st, 2026
Have other questions? Contact MGHCSRP@MGB.ORG
| |
The MGH Claflin Distinguished Scholar Awards
for Junior Faculty Women Investigators
Applications are now being accepted by the Executive Committee on Research (ECOR) for the Claflin Distinguished Scholar Awards!
What are the Claflin Awards?
Although women scientists are recruited to Massachusetts General Hospital (MGH) programs, their advancement to senior faculty positions is still far less frequent than that of their male counterparts. In 1993, The Women in Academic Medicine Committee, originally chaired by Mrs. Jane D. Claflin, Honorary Trustee, was established to facilitate the academic careers of women in science at MGH. Recognizing that a significant obstacle to career advancement is the difficulty of maintaining research productivity alongside the responsibilities of parenting, this Committee, with the sponsorship of the Executive Committee on Research (ECOR), established the Claflin Distinguished Scholar Awards. It is intended that this funding will increase opportunities for women to advance to senior positions in academic medicine.
How much is each award?
These are two-year awards for $60,000 per year in direct costs, plus 20% for indirect costs.
When is the deadline?
Wednesday, January 29, 2025 - 5:00 PM
| |
Limited Submission Funding Opportunities
We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.
CURRENT OPPORTUNITIES:
See full details for all awards on our website.
| |
Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
MGH LOI Deadline: 11/13/24
Learn more
| |
NCI National Clinical Trials Network – Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)
MGH LOI Deadline: 12/11/24
Learn more
| |
Foundation Funding Opportunities
Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.
For all open foundation funding announcements, see the MGB Innovation External Funding Database
CURRENT OPPORTUNITIES:
See this week’s full foundation funding announcements (including eligibility, RM deadlines, and IDC) on our website.
-
John and Elizabeth Leonard Family Foundation Basic Cancer Research Fellowship, American Association for Cancer Research (AACR). $120,000 (IDC Exempt). LOI Deadline: December 17
-
The Sagol Network GerOmic Award for Junior Faculty, American Federation for Aging Research (AFAR). $150,000 (8% IDC). LOI Deadline: December 16
-
NEW! Common Mechanisms in Autoimmunity Insight Awards, Breakthrough T1D (formerly JDRF). $150,000 (10% IDC). Application Deadline: January 9
-
Young Investigator Award (YIA), Children's Tumor Foundation (CTF). $200,000 (10% IDC). LOI Deadline: December 2
-
Clinical Trials in Thalassemia Cell and Gene Therapy, Cooley's Anemia Foundation. $150,000 (8% IDC). LOI Deadline: December 16
-
Gilead Sciences Research Scholars Program in Solid Tumors, Gilead Sciences, Inc. $180,000 (10% IDC). Application Deadline: December 6
-
Translational Research Grants in Thoracic Oncology, International Association for the Study of Lung Cancer (IASLC). $200,000 (No IDC). Application Deadline: January 8
-
Career Development Award, International Myeloma Society (IMS). $75,000 (8% IDC). Application Deadline: January 31
-
IMS and Paula and Rodger Riney Foundation Translational Research Award, International Myeloma Society (IMS). $250,000 (8% IDC). Application Deadline: January 31
-
Psoriatic Disease Research Fellowships, National Psoriasis Foundation (NPF). $50,000 (No IDC). Application Deadline: January 31
-
Traditional Grants (multiple opps), National Psoriasis Foundation (NPF). $200,000 (No IDC). Application Deadline: January 31
-
Young Investigator Award, Tourette Association of America. $150,000 (10% IDC). LOI Deadline: December 16
| Do you want to learn more about identifying external funding opportunities? Please click here to request a research consultation with Amy Robb or see ECOR’s website for information on the Pivot database. | |
Apply for the 2025 Claflin Consultation Initiative
Applying for the Claflin Awards? ECOR and the Office for Women’s Careers are offering help with your application.
If you are applying for a Claflin Award, and would like help preparing your application, ECOR and the Office for Women’s Careers (OWC) encourages you to take advantage of the Claflin Consultation Initiative (CCI) for applicants.
The CCI is designed to help eligible faculty prepare their best application for the 2025 Claflin Distinguished Scholar Awards. Many prior Claflin winners have volunteered their time to answer questions and offer guidance and encouragement to potential applicants. Coaches may give advice on all aspects of the application, including the research plan, budget, and the description of child-rearing responsibilities.
Please click here to enroll in the Claflin Consultation Initiative by Monday, December 2.
We encourage you to attend the Claflin panel discussion on November 20 from 9:00 – 10:00am. Please refer to the call for more details.
To review your eligibility please click here or email ecor@mgh.harvard.edu before registering for the CCI.
| |
TODAY! Speed Mentoring Hour
Friday, November 8, 2024, 12:00 – 1:00 pm, Zoom
Sponsored by the Center for Faculty Development
Every month, two mentor leaders from different departments will answer your questions about any aspect of being a mentee or mentor. You do not need to be in the same department as the leaders—this event is open to faculty across MGH, but registration is required. Come ready with your questions and be ready to learn not only from the senior mentoring leaders but also from fellow attendees.
This session is scheduled for November 8, 12 – 1 pm, with Steven Greenberg, MD, PhD, Vice-Chair, Faculty Development and Promotions, MGH Department of Neurology; and Jason Harris, MD, Associate Chief for Academic Faculty Affairs and Development, Department of Pediatrics.
Mentor leaders will meet with up to 8 faculty members, each given 7-8 minutes to ask questions on any aspect of mentoring or being mentored and receive input from the mentor leaders.
Open to faculty across MGH, registration is required.
| |
MONDAY! Faculty Transition Webinar Series S1 -
"Successful Transition to Retirement While Balancing Continued Engagement at MGH"
Monday, November 11, 2024, 4:00 - 5:00pm, Zoom
Sponsored by the Center for Faculty Development
The Center for Faculty Development’s Office for Senior Faculty Transitions invites you to join a panel of MGH faculty members who transitioned to retirement while finding opportunities to stay engaged in academic activities, such as teaching and mentoring.
Panelists:
Jeffrey B. Cooper, MD, Founder, Center for Medical Simulation
Ann-Christine Duhaime, MD, Pediatric Neurosurgeon
Robert Rollings, MD, Research Fellow, Cardiovascular Imaging Research Center
Isaac Schiff, MD, former Chief of Obstetrics & Gynecology
Anne B. Young, MD, PhD, former Chief of Neurology, currently researcher and clinician
Click to register
| |
A Practical Guide to Leveraging the Mass General Brigham Biobank and All of Us Research Program for Genetic and Biomarker Research
When: Tuesday, 11/12/24 | 1:00-4:30 pm
Course Director: Jordan Smoller, MD, ScD, Director, Psychiatric and Neurodevelopmental Genetics Unit, MGH
Location: Virtual via Zoom
Description:
Recent years have seen the rise of precision medicine as an organizing framework for biomedical research. Mass General Brigham has emerged as a leader in this new paradigm, facilitated partly by the availability of the Mass General Brigham (MGB) Biobank and involvement in the NIH All of Us Research Program. With more than 150,000 participants enrolled, broad clinical data, biospecimens, and genomic data, the MGB Biobank offers a powerful resource for basic, clinical/translational, omics, and biomarker research. The All of Us Research Program, with more than 800,000 participants, offers a national research resource that includes electronic health records, genomic, survey, and other data and is broadly accessible to MGH researchers. The MGH Division of Clinical Research Omics Unit is sponsoring a mini course focused on how investigators may leverage the MGB Biobank and the All of Us Research Program for genetic, biomarker, and observational research. The course will include an overview of these resources, practical tips on conducting research, and illustrative use cases.
| |
Course: Qualitative and Mixed Methods:
Mixed Methods Research
QMMR: Mixed Methods Research
Speakers: Rachel Vanderkruik, PhD and Vanessa Merker, PhD
When: Tuesday, 11/12/24 | 10:00-11:00 am
Location: Virtual via Zoom
Description:
Sponsored by the MGRI Division of Clinical Research and the Mongan Institute
This one-session course will introduce clinical investigators to the principles and practices of mixed-method research. Mixed methods research is an approach to collecting, analyzing, and integrating both quantitative and qualitative research and methods within a study. This course will summarize how integration in mixed methods research can occur at the research design, methods, and/or interpretation and reporting levels. We will highlight the value of mixed methods approaches and common misconceptions. Examples of how mixed methods research can be used in healthcare will be provided.
This course is intended for MGH researchers but is available to all across MGB.
| |
Gene and Cell Therapy Research Symposium
November 12-13, 2024, MGH Assembly Row
The 2nd annual Gene and Cell Therapy Research Symposium will take place November 12-13, 2024, bringing together Mass General Brigham researchers and clinicians dedicated to advancing gene and cell therapy. There will be opportunities for networking and collaboration among attendees and engaging discussions led by MGH researchers:
| |
- Sharl Azar, MD
- Edwin Choy, MD, PhD
- Allan Goldstein, MD
- Max Jan, MD, PhD
| |
- Clotilde Lagier-Tourenne, MD, PhD
- Marcela Maus, MD, PhD
- Patricia Musolino, MD, PhD
- Jeff Schweitzer, PhD, MD
| |
Drop-In Sessions for CRC's
When: Wednesday, 11/13/24 | 12:00-1:00 pm
Location: Virtual via Teams
Join Here!
Are you a clinical research coordinator? Do you have questions about MGB or MGH clinical research processes or systems, who to contact, and the next steps? We are here to help. Come to the DCR’s Virtual Drop-In Sessions for CRCs! Get answers to all of your clinical research operations questions from experienced members of the DCR and chat with your fellow CRCs. Drop-in sessions are hosted on MS Teams bi-weekly on Wednesdays from Noon to 1:00 PM starting June 12th.
|
Imaging Data Commons: Data + Tools +
Compute to Power Your AI Explorations
Artificial Intelligence for Clinicians (AI4C) Lecture Series
Presented by Mass General Brigham AI
Andrey Fedorov, PhD
Thursday, November 14th, 12pm ET
Andrey Fedorov, PhD, is a researcher at Brigham and Women's Hospital (BWH) and Associate Professor in Radiology at Harvard Medical School. Andrey is one of the leads of the team tasked with building National Cancer Institute Imaging Data Commons (IDC). A computer scientist by training, Andrey spent the past 15 years at the BWH Surgical Planning Lab working on translation and evaluation of image computing tools in clinical research applications. He is dedicated to developing infrastructure and best practices to help imaging researchers improve transparency of their studies, simplify data sharing and make their analyses more easily accessible and reproducible by others.
Rapid advances in technology open the possibility to fundamentally change medical imaging research. Ever-increasing capabilities of Graphical Processing Units (GPU) defied processing performance growth expectations. This, in turn, precipitated revolution in Artificial Intelligence, enabling automation of medical image analysis tasks that remained unsolved for decades. Advancements in virtualization and cloud computing provide unprecedented computational power without extensive investment into on-premises infrastructure. Open source development of innovative AI tools became the norm, streamlining access to the latest advances in AI, their evaluation and refinement.
National Cancer Institute Imaging Data Commons (IDC) is a cloud-based environment containing ~80TB of public cancer imaging data, opening new opportunities to leverage these technology advances for the development of robust cancer image analysis tools. IDC supports life-cycle of imaging data from curation into standard representation and harmonization of metadata on ingestion, to integration with cloud-based tools for seamless visualization and exploration, application of analysis workflows, and continuous enrichment of the images with annotations and analysis results. I will give an overview of IDC focusing on its capabilities, opportunities and examples of enabling AI-driven analysis, and the potential to catalyze collaboration and discovery in medical imaging research.
|
Boston Angiogenesis Meeting 2024
Friday, November 15, 2024, 9:00 am – 5:00 pm, Simches Research Center
Meeting Chair: Dan G. Duda, DMD, PhD, FAIMBE, FAAAS, FASGO, Professor of Radiation Oncology, Harvard Medical School, Investigator, Edwin L. Steele Laboratories for Tumor Biology, Massachusetts General Hospital Research Institute
Director of Translational Research in GI Radiation Oncology, Massachusetts General Hospital
|
Fun Fridays- Eight Active Ingredients of Tai Chi©
Friday, November 15, 2024, 12:00 – 1:00 pm, Zoom
Sponsored by the Center for Faculty Development’s Office for Well-Being
Fun Fridays offer a refreshing mid-day break from work to indulge in physical, mental, or creative activity.
Join Eight Active Ingredients of Tai Chi© certified teacher Barry Friedman in exploring the traditional principles of Tai Chi in a relaxed, informal and experiential session. Regular practice of this gentle “meditation in motion” leads to more vigor and flexibility, better balance and mobility, and an overall sense of well-being.
Presenter: Barry Friedman is a long-term committed practitioner of tai chi, teaches regularly to his own classes as well as at the Tree of Life tai chi studios in Watertown, and brings his experience as a life-long soccer goalkeeper coach to bear in providing a welcoming environment for the cultivation of fitness, health and mental well-being.
Click to register
|
REDCap MyCap
Speakers: Daniel Foley, Applications Analyst II, and Jeremy Alphonse, Project Analyst II, Research Information Science and Computing (RISC) Applications and Services
When: Friday, 11/15/24 | 11:00 am-12:00 pm
Location: Virtual via Zoom
Description:
MyCap, a new feature now available in REDCap, is a customizable participant-facing mobile application (app) that captures patient-reported outcomes based on a REDCap project. MyCap collects data through surveys and the automated administration of active tasks (activities performed by participants using mobile device sensors under semi-controlled conditions) from any mobile device (iOS or Android).
Learning Objectives:
- MyCap Overview: Explain what the MyCap Mobile App can provide participants and researchers, identify likely research projects that would benefit from MyCap, and review the process for requesting access to the tool.
- MyCap Build Process: A demonstration on how to setup a MyCap enabled project will be included. Activation of surveys/tasks/active tasks will be provided.
- Future MyCap Improvements: A discussion of upcoming features available for MyCap enabled projects will be shown.
-
More information about MyCap can be found at: https://confluence.partners.org/display/MRRC/MyCap+Application
REDCap link: https://rc.partners.org/research-apps-and-services/collect-data#redcap
|
Research Recharge
A social and networking event hosted by the MGH Center for Diversity and Inclusion
Monday, November 18, 12p – 1p
CNY 149 – 2-220
To RSVP, click here
The Center for Diversity and Inclusion is dedicated to building a diverse research workforce at Mass General Hospital. The Research Recharge is time set aside for the MGH underrepresented in medicine (UiM) research community to engage and build valuable connections.
Lunch will be served!
Please email cdi@mgh.harvard.edu if you have any questions or concerns.
|
Parenting Series 2024-2025:
“The Ins and Outs of Paternity Leave”
Monday, November 18, 2024 • 12:00 – 1:00 pm, Zoom
Sponsored by the Center for Faculty Development’s Office for Women’s Careers
The Parenting Series is an Office for Women’s Careers initiative focused on well-being and work-life balance for MGH faculty and trainee parents.
This panel will present the logistics as well as the lived experience of taking paternity leave, a benefit that has received less attention than maternity leave but that is also of crucial value and importance.
Panelists:
-
Daniel Hall, PhD, Assistant Professor of Psychiatry, HMS
-
Mitchel B. Harris, MD, Professor of Orthopedic Surgery, HMS
-
Darshan Mehta, MD, MPH, Assistant Professor of Medicine and Psychiatry, HMS
-
Virginia Rosales, HR/Benefits Manager, Professional Staff Compensation and Benefits Office
Click to register
| |
Clinical Trial Opportunities for Young Investigators:
Partnering with the TCRC
Speakers: Mason Freeman, MD, Director, Translational Research Group, MGH, and Melanie Haines, MD, Neuroendocrine Unit, MGH, and Joshua Salvi, MD, PhD, Department of Psychiatry, MGH
When: Monday, November 18, 2024 | 2:00-3:00 pm
Location: Virtual via Zoom
- Opportunities for junior investigators to become involved in industry-sponsored clinical trials
- Assess junior investigators' interest in a certificate course/training for investigators conducting industry-sponsored trials
- Career pathways for investigators interested in conducting industry trials
| |
Claflin Distinguished Scholar Awards Panel Discussion
Wednesday, November 20, 2024, 9:00 – 10:00am, Zoom Meeting
Would you like to know more about the Claflin Distinguished Scholar Awards?
These awards are designed to provide bridge funding for women with an HMS faculty appointment of instructor or assistant professor, to sustain research productivity alongside the responsibilities of parenting, with the intention of advancing women in academic medicine. The discussion will cover:
- Eligibility requirements
- Resources to improve your application
- Advice from recent Claflin Scholars
- How the award can advance your career
Join Zoom Meeting
https://partners.zoom.us/j/83468202869
Meeting ID: 834 6820 2869
Find your local number: https://partners.zoom.us/u/kbK6AlZx9Z
| |
Biobank Portal
Speaker: Stacey Duey, Assistant Director, RISC
When: Wednesday, 11/20/24 | 10:00 – 11:00 am
Location: Virtual via Zoom
Description:
This course will introduce the use of the Biobank Portal application for clinical research, including reviewing healthcare data, types of samples available, genomic information, and requesting data. The course is geared toward investigators and staff at all levels interested in the utility and information of the Biobank Portal for research.
|
“How Do You Feel?”, a moderated discussion with Dr. Jessi Gold
Wednesday, November 20, 2024, 12:00 – 1:00 pm
In-person in Bulfinch-450 with virtual option
Dr. Jessi Gold is the Chief Wellness Officer of the University of Tennessee System and is a psychiatrist who cares for healthcare workers, faculty, and young adults. Dr. Shannon Scott-Vernaglia, Director of the Office of Clinical Careers, will moderate a discussion with her about her new book, “How Do You Feel?"
The first 30 to register will receive a copy of the book via interoffice mail. You must have an interoffice mailing address on-campus or pick up the book at the event.
Presenter
Psychiatrist Jessi Gold, MD, MS, is the Chief Wellness Officer of the University of Tennessee System and an associate professor in the Department of Psychiatry at the University of Tennessee Health Science Center. She is a fierce mental health advocate and highly sought-after expert in the media on everything from burnout to celebrity self-disclosure. Dr. Gold has written widely for the popular press, including for The New York Times, The Atlantic, InStyle, Slate, and Self. In her clinical practice, she sees health care workers, trainees, and young adults in college. A graduate of the University of Pennsylvania (with a degree in anthropology), the Yale School of Medicine, and the Stanford University Department of Psychiatry, she spends her free time traveling with her friends, watching live music (especially Taylor Swift) or mindless television, and on walks with her dog, Winnie. Find her on X, Instagram, TikTok, or Threads @DrJessiGold.
Click to register
| |
Maurizio Fava Lecture Series on Well-Being:
“Reading Kafka in the Hospital Cafeteria - Reflections on 17 years of Literature and Medicine at MGH”
Thursday, November 21, 2024, 12:00 – 1:00 pm
Sponsored by Center for Faculty Development’s Office for Well-Being
The Maurizio Fava Lecture Series on Well-Being was created to honor Dr. Fava’s vision and advocacy for well-being of the MGH community.
Reading literature has been shown to increase empathy and enhance clinical and academic skills. At MGH we have had a monthly literature and medicine discussion group for 17 years. How has reading and discussing the works of Shakespeare, Toni Morrison, Kazuo Ishiguro, and many other writers improved our personal and professional lives? Can poetry and prose heal burnout? In this lecture Dr. Koven will address these questions and also trace the long tradition of narrative in medicine.
Learning Objectives:
Upon completion of this activity, participants will be able to:
• Explore the role has narrative played in the evolution and practice of medicine.
• Analyze how reading literature can improve patient care and caregiver satisfaction.
• Understand how writing literary narrative contributes to clinical and academic medical faculty well-being.
Target Audience: This activity is intended for physicians with any specialty.
Course Director: Joshua N. Goldstein, MD, PhD, Director, Center for Faculty Development (CFD) and Professor of Emergency Medicine.
Presenter:
Suzanne Koven, MD, received her B.A. in English literature from Yale and her M.D. from Johns Hopkins. She also holds an M.F.A. in nonfiction from the Bennington Writing Seminars. After her residency training and chief residency in medicine at Johns Hopkins Hospital, she joined the faculty of Harvard Medical School and practiced primary care internal medicine at Massachusetts General Hospital for over 30 years. She is an associate professor of medicine and global health and social medicine at Harvard Medical School and holds the Valerie Winchester Family Endowed Chair in Primary Care Medicine at Mass General. In 2019 she was named inaugural Writer in Residence at Mass General. Her essays, articles, blogs, and reviews have appeared in The Boston Globe, The New England Journal of Medicine, The Lancet, NewYorker.com, Psychology Today, The L.A. Review of Books, The Virginia Quarterly, STAT, and other publications. Her monthly column “In Practice” appeared in The Boston Globe and won the Will Solimene Award for Excellence in Medical Writing from the American Medical Writers Association. Dr. Koven co-directs the Media and Medicine program at Harvard Medical School and speaks to a wide variety of audiences on literature and medicine and the role of women in medicine. Her essay collection, Letter to a Young Female Physician, was published by W.W. Norton & Co. in 2021. Her memoir, the Mirror Box, will be published by W.W. Norton & Co. in 2026.
Click to register
| |
Course: Introduction to RPDR
Speaker: Stacey Duey, Assistant Director, RISC
When: 11/21/24 | 11:00 am-12:30 pm
Location: Virtual via Zoom
Description:
The Research Patient Data Registry (RPDR)* brings clinical information to the researcher's fingertips and ensures the security of patient information by controlling and auditing patient data distribution within the guidelines of the IRB.
This course will introduce the use of the RPDR (Research Patient Data Registry) application for clinical research, including reviewing healthcare data, creating a query, and requesting data. The course is geared toward investigators and staff at all levels interested in the utility and information of the RPDR for research.
*Link requires you to be on an MGB workstation or VPN.
|
Course: Conquering the K Workshop
Speaker: Andrew A. Nierenberg MD, Co-Director, Center for Clinical Research Education
When: Thursday, 11/21/24 | 1:30-3:30 pm
Location: Virtual via Zoom
Description:
This course is sponsored by the MGH Division of Clinical Research
This is a workshop for applicants of R Grants. Bring one section of your upcoming R grant to review and discuss with fellow applicants and one of our experienced faculty!
|
Course: REDCap eConsent Functionality
Speakers: Daniel Foley, Applications Analyst II, and Jeremy Alphonse, Project Analyst II, Research Information Science and Computing (RISC) Applications and Services
When: 11/21/24 | 10:00-11:00 am
Location: Virtual via Zoom
Description:
Mass General Brigham (MGB) has developed a REDCap eConsent Framework that will turn the paper-based informed consenting processes into an electronic informed consent process that researchers can use for Institutional Review Board (IRB) reviewed and approved studies. The MGB REDCap eConsent Framework will allow users to combine the validated components to design and customize an eConsent Project to their Use Case and workflow.
Learning Objectives:
- Understand eConsent technical requirements
- Learn how to program REDCap for electronic consent
Target audience: Researchers evaluating electronic consent options for research studies.
REDCap link: https://rc.partners.org/research-apps-and-services/collect-data#redcap
|
Summit: Transforming Post-Acute Care Access
for Severe Traumatic Brain Injury
On November 22, 2024, the Spaulding-Harvard Traumatic Brain Injury Model System (SH-TBIMS) will host a pivotal virtual summit, "Improving Access to Post-Acute Care for People with Severe Traumatic Brain Injury: A Call to Action." This summit will bring together leaders in healthcare, research, and policy to address critical gaps in access to rehabilitation for people with severe TBI and work toward solutions for equitable care.
Summit Highlights:
The SH-TBIMS Summit will spotlight:
-
The State of Science in TBI Recovery: Reviewing current research on recovery and outcome after severe TBI.
-
Barriers to Care: Examining policies, like the “three-hour rule,” that limit access to inpatient rehabilitation, especially for individuals with disorders of consciousness.
-
Pathways to Change: Showcasing effective partnerships and advocating for policy adjustments to increase rehabilitation access and improve long-term outcomes.
Why It Matters
Currently, fewer than 15% of individuals with severe TBI receive vital inpatient rehabilitation, often due to policy restrictions that inadvertently exclude those with the highest needs. The summit aims to foster dialogue and action toward health equity, ensuring that all individuals with TBI have a pathway to recovery. We hope to engage diverse participants, including representatives from federal and state healthcare funding agencies, commercial insurance companies, research funding agencies, legislative committees, consumer advocacy groups, academic institutions, and professional organizations.
There is no fee for registration; register using this link: SH-TBI Summit Registration.
Complementary Event
Leavitt Partners will host a follow-up virtual workshop on December 4, 2024. This session will delve deeper into the “three-hour rule,” its impact on care access, and evidence-based alternatives to better serve the TBI community.
This event is open to the public; register using this link: Three-Hour Rule Workshop Registration.
| |
Endocrine Grand Rounds
36th Annual Farahe Maloof Lectureship
“Strategic Treatment of Anaplastic Thyroid Cancer:
The Reach for a Cure”
Tuesday, December 3rd, 2024
12-1PM
MGH Ether Dome, Bulfinch 4
In-Person Event
Presented by Maria E. Cabanillas, MD
Oncologic Endocrinologist, University of Texas MD Anderson Cancer Center;
Tenured Professor & Faculty Director, Clinical Research,
Department of Endocrine Neoplasia at MD Anderson, Houston, TX
Upon completion of this activity, participants will be able to:
- Describe the necessary testing for adequate treatment of ATC
- Describe novel strategic therapies to anticipate resistance to therapy
- Understand the appropriate use of FDA-approved therapies for ATC & investigational uses of novel therapies
Target Audience: This activity is intended for Endocrinologists and Health Care Professionals with an interest in Endocrine Topics
Course Director: Frances J. Hayes, MD, MB, BCh, BAO
Accreditation: In support of improving patient care, Mass General Brigham is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Mass General Brigham designates this live activity for a maximum of 1 AMA PRA Category 1 Credit TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
| |
Course: Introduction to 10x Single-Cell Platforms and Workflows
Speakers: Ruslan Sadreyev, PhD, Director of Bioinformatics
When: 12/3/25 | 3:00-5:00 pm
Location: Hybrid | Simches Room 3-120 and Zoom
Description:
A lot has changed in the world of sample preparation for single-cell transcriptomics. Listen to a scientist from 10x Genomics discuss the latest updates. Learn tips for success when working with fixed samples, even FFPE, and how you can access samples that were previously too challenging to work with.
The course will cover the fixation of solid tissue, cells in suspension, and how to isolate cells from FFPE blocks.
We will also briefly cover all the new advancements in 10x Single Cell assays available through the core.
| |
Parenting Series 2024-2025: “What Parents Should Know about Gender Diversity in Kids and Teens”
Friday, December 13, 2024, 12:00 – 1:00 pm, Zoom
Sponsored by the Center for Faculty Development’s Office for Women’s Careers
The Parenting Series is an Office for Women’s Careers initiative focused on well-being and work-life balance for MGH faculty and trainee parents.
There has been increasing awareness and recognition of transgender and gender-diverse identities in children, adolescents, and adults. This talk will provide parents and caregivers with information about diverse gender identities and best practices for supporting gender-expansive youth. It will dispel misconceptions about gender-affirming care and offer an opportunity for parents to ask relevant questions about their children and families.
Speaker:
Aude Henin, PhD, is Founding Co-Director of the Child Cognitive-Behavioral Therapy Program, Clinical Director of the Child Resiliency Program, and Director of Psychological Services in the Gender Identity Program at the Massachusetts General Hospital. Dr. Henin has served on the Massachusetts Commission for LGBTQ Youth for the past 5 years. She specializes in the assessment and cognitive-behavioral treatment of children with mood, developmental, and anxiety disorders. She also specializes in working with transgender and gender-diverse youth and their families.
Click to register
|
Two Meditation Sessions available every week
Two Meditation Sessions available every week
SESSION 1: Meditation Monday with Dr. Darshan Mehta
Every Monday, 8:00 – 8:30 am, Zoom à next session, Monday, November 11!
Co-sponsored by the Center for Faculty Development’s Office for Well-Being and the MGPO Frigoletto Committee
Join Darshan Mehta, MD, MPH, Director, Office for Well-Being, for a guided meditation session on Monday morning.
Register and add to calendar
SESSION 2: Midweek Meditation with Guest Leader
Every Wednesday, 8:00 – 8:30 am, Zoom à next session, Wednesday, November 13!
Sponsored by the Center for Faculty Development’s Office for Well-Being
Join guest leaders, nuns from the Great Wisdom Buddhist Institute (GWBI), for next Wednesday’s guided meditation session.
Register and add to calendar
| | | | |